The ethics of direct-to-consumer ads from pharmaceutical companies is being debated as the FDA looks towards possibly banning them altogether.
Two-thirds of pharmaceutical companies did not proactively release the launch price of their medications from 2022 to 2024. Objective: To examine how drug manufacturers disclosed prices for new ...
Direct-to-consumer drug advertising has long been opposed by the American Medical Association — and now the Trump administration has targeted it too.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results